Brief #58356Updated 18 NOV 2025LOS ANGELESSOFTWARE COMPANIESSERIES B
Employbl DossierNammi Therapeutics
Nammi Therapeutics is an immunotherapy company that develops nano-enabled chemo-immunotherapy for the treatment of cancer.
- Founded
- 2018
- Headcount
- 8
- Open roles
- 0
- Last raised
- Series B · $1M
Section II · Premium ProfileMembers only
- 01Engineering interview process at Nammi TherapeuticsLocked
- 02Tech stack & infrastructure choicesLocked
- 03Culture & day-to-day work styleLocked
- 04Why join now vs. 6 months from nowLocked
- 05Hiring focus & open headcount by teamLocked
- 06Comp philosophy and band contextLocked
7-day free trial · $25/mo · cancel anytime
